PALVELLA THERAPEUTICS, INC.: SELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Microcystic Lymphatic Malformations

PALVELLA THERAPEUTICS, INC. (Wayne, Pennsylvania): SELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Microcystic Lymphatic Malformations. Its award of $484,481 is above the median of $407,048 (58th percentile). Dated 49 days ago, it serves as a historical benchmark. Score 55/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

award: $484,481 · 58th percentile of 10,712 NihBiotechGrantPulse records · 1.2x the median

Free preview: all 10 published fields of this record are shown below. Locked: 499 related PA NihBiotechGrantPulse records and the 5-column CSV export.

FieldValue
OrganizationPALVELLA THERAPEUTICS, INC.
LocationWAYNE, PA
ProjectSELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Microcystic Lymphatic Malformations
Project number5R01FD008196-03
MechanismR01
InstituteFood and Drug Administration
Award$484,481
Awarded2026-09-17
Project period2024-09-20 to 2028-08-31
UEIKTH1B7KWRCN9
award percentile58th of 10,712 (median $407,048, 1.2x median)
Peer records CSV (500 PA records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch PALVELLA THERAPEUTICS, INC.

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock PALVELLA THERAPEUTICS + 500 PA peer records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL

  • Source agency: NIH RePORTER (newly awarded projects)
  • Record date: 2026-09-17
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all PA records free →

Top NihBiotechGrantPulse records (PA first): ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · NRG ONCOLOGY FOUNDATION, INC. · UNIVERSITY OF PENNSYLVANIA · UNIVERSITY OF PENNSYLVANIA · UNIVERSITY OF PENNSYLVANIA · Browse all by state and category →

LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: PALVELLA THERAPEUTICS, INC. and 636 Pennsylvania peers

  • Pennsylvania NihBiotechGrantPulse records like this one: 636
  • PALVELLA THERAPEUTICS, INC.'s award: 58th percentile of 10,712 records
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every Pennsylvania peer: $127,200 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more NihBiotechGrantPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

55 / 100 Lab Budget Score

  • Award of $400K or more.
  • Research or center grant: supplies, instruments and services budget.

What is the NihBiotechGrantPulse record for PALVELLA THERAPEUTICS, INC. in Wayne, Pennsylvania?

PALVELLA THERAPEUTICS, INC. received an NIH award of $484,481 on 2026-09-17: SELVA: A Multicenter, Phase 3 Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Microcystic Lymphatic Malformations.

How does PALVELLA THERAPEUTICS, INC. compare to other Pennsylvania NihBiotechGrantPulse records?

Its award of $484,481 sits in the upper half (58th percentile) of 10,712 records; the median is $407,048. It is 49 days old; check the official source for later updates before acting.

PALVELLA THERAPEUTICS, INC. vs. top 3 peers

OrganizationLocationAmountPercentileRecord date
PALVELLA THERAPEUTICS, INC.WAYNE, PA484,48158th2026-09-17
UNIVERSITY OF PITTSBURGH AT PITTSBURGHPITTSBURGH, PA462,85656th2026-10-26
UNIVERSITY OF PITTSBURGH AT PITTSBURGHPITTSBURGH, PA672,88172nd2026-10-26
UNIVERSITY OF PITTSBURGH AT PITTSBURGHPITTSBURGH, PA678,53073rd2026-10-26

Related records

NihBiotechGrantPulse: records in Pennsylvania NihBiotechGrantPulse: Research project grants (R)

More Pennsylvania public-record feeds

Pennsylvania Air Quality Continuous Emission Monitoring System 1986 Pulse in Pennsylvania Bank Branch Openings, Closings & Mergers by State in Pennsylvania SEC 8-K Corporate Trigger Events in Pennsylvania EPA Brownfields Award Tracker in Pennsylvania Pennsylvania Sales, Use & Hotel Occupancy Tax Licenses and Certificates Cur in Pennsylvania Carrier Out-of-Service Alerts in Pennsylvania Industrial Environmental Noncompliance Radar in Pennsylvania New FDA Medical Device Listings by Manufacturer, CMO & Sterilizer in Pennsylvania

How to monitor PALVELLA THERAPEUTICS, INC. and peer research project grants (r) records

Get new NihBiotechGrantPulse records like PALVELLA THERAPEUTICS, INC. by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together